TrialLancet (London, England)2010

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

Frederick J Raal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.